Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids
暂无分享,去创建一个
A. Levine | N. Pavletich | B. Elenbaas | J. Bayle | L. Wu | L. Wu
[1] A. Levine,et al. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. , 1994, Genes & development.
[2] A. Levine,et al. p53 and E2F-1 cooperate to mediate apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[3] M. Kulesz-Martin,et al. Endogenous p53 protein generated from wild-type alternatively spliced p53 RNA in mouse epidermal cells , 1994, Molecular and cellular biology.
[4] L. Szekely,et al. p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. E. Stenger,et al. p53 domains: identification and characterization of two autonomous DNA-binding regions. , 1993, Genes & development.
[6] X. Chen,et al. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. , 1993, Genes & development.
[7] C. Pabo,et al. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. , 1993, Genes & development.
[8] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[9] S. Elledge,et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.
[10] U. Ramsperger,et al. p53‐catalyzed annealing of complementary single‐stranded nucleic acids. , 1993, The EMBO journal.
[11] Scott W. Lowe,et al. p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.
[12] C. Purdie,et al. Thymocyte apoptosis induced by p53-dependent and independent pathways , 1993, Nature.
[13] G. Zambetti,et al. Wild-type p53 binds to the TATA-binding protein and represses transcription. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[14] E. Shaulian,et al. Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding , 1992, Molecular and cellular biology.
[15] Thea D. Tlsty,et al. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53 , 1992, Cell.
[16] G. Wahl,et al. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles , 1992, Cell.
[17] M. Remm,et al. A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization. , 1992, Oncogene.
[18] A. Levine,et al. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[19] P. Friedman,et al. Wild-type p53 activates transcription in vitro , 1992, Nature.
[20] A. Levine,et al. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.
[21] P. Shaw,et al. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[22] M. Kulesz-Martin,et al. Alternatively spliced p53 RNA in transformed and normal cells of different tissue types. , 1992, Nucleic acids research.
[23] B. Vogelstein,et al. Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.
[24] V. Rotter,et al. Involvement of wild-type p53 protein in the cell cycle requires nuclear localization. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[25] M. Yaniv,et al. Wild-type p53 can down-modulate the activity of various promoters. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[26] A. Kimchi,et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 , 1991, Nature.
[27] B. Vogelstein,et al. Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication , 1991, Cell.
[28] A. Levine,et al. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. , 1991, Genes & development.
[29] G. Lozano,et al. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. , 1990, Science.
[30] S. Fields,et al. Presence of a potent transcription activating sequence in the p53 protein. , 1990, Science.
[31] O. Halevy,et al. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53 , 1990, Cell.
[32] P. Friedman,et al. Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[33] T. Maimets,et al. p53 interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis. , 1990, Oncogene.
[34] A. Levine,et al. Purification of complexes of nuclear oncogene p53 with rat and Escherichia coli heat shock proteins: in vitro dissociation of hsc70 and dnaK from murine p53 by ATP , 1988, Molecular and cellular biology.
[35] L. Banks,et al. Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. , 1986, European journal of biochemistry.
[36] J. Yewdell,et al. Monoclonal antibody analysis of p53 expression in normal and transformed cells , 1986, Journal of virology.
[37] V. Rotter,et al. Isolation of a full-length mouse cDNA clone coding for an immunologically distinct p53 molecule , 1985, Molecular and cellular biology.
[38] W. Maltzman,et al. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells , 1984, Molecular and cellular biology.
[39] D. Pim,et al. Monoclonal antibodies specific for simian virus 40 tumor antigens , 1981, Journal of virology.
[40] K. Kinzler,et al. Oncogenic forms of p53 inhibit p53-regulated gene expression. , 1992, Science.
[41] J. Milner,et al. A new anti-p53 monoclonal antibody, previously reported to be directed against the large T antigen of simian virus 40. , 1987, Oncogene.